Oramed Pharmaceuticals In...
2.35
-0.01 (-0.42%)
At close: Jan 15, 2025, 3:59 PM
2.34
-0.21%
After-hours Jan 15, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Net Income 5.09M -37.76M -22.99M -11.51M -14.36M -12.73M -10.48M -10.96M -7.23M -5.70M -4.23M -3.34M -1.56M -2.98M -2.76M -2.77M -3.24M -414.58K -45.78K -720.00K -50.00K
Depreciation & Amortization 196.00K 58.00K 77.00K 7.00K 8.00K 6.00K 5.00K 4.00K 4.00K 6.00K 5.38K 14.74K 28.30K 31.86K 30.49K 15.45K 108.00K n/a n/a n/a n/a
Stock-Based Compensation 4.21M 11.51M 2.69M 1.17M 808.00K 1.55M 1.57M 634.00K 1.35M 1.47M 719.22K 271.16K 529.33K 807.83K 553.20K n/a n/a n/a n/a n/a n/a
Other Working Capital -471.00K -567.00K -3.38M -2.34M -211.00K -2.99M 1.62M 14.57M 346.00K -314.00K -207.11K 56.53K -38.89K 879.96K -453.18K 135.16K -17.00K 49.28K 5.35K n/a -7.93M
Other Non-Cash Items -17.09M -778.00K 1.04M 38.00K 55.00K 99.00K 72.00K 101.00K 93.00K 102.00K 244.46K 250.56K -1.33M 253.63K 360.41K 781.70K 2.25M 3.68K n/a 420.00K n/a
Deferred Income Tax n/a n/a -689.00K 1.01M 254.00K 22.00K 124.00K -163.00K -20.00K -109.00K 220.76K 246.75K 725.65K 335.00 641.00 n/a n/a n/a n/a n/a n/a
Change in Working Capital -2.70M -943.00K -1.31M -3.16M 290.00K -3.60M 2.87M 15.04M 862.00K 161.00K -353.34K 259.66K -56.18K 465.25K -453.18K 135.16K 268.00K 49.28K 5.35K 10.00K 10.00K
Operating Cash Flow -10.29M -27.92M -21.18M -12.44M -12.94M -14.66M -5.83M 4.66M -4.95M -4.07M -3.40M -2.30M -1.67M -1.42M -2.27M -1.84M -611.00K -361.61K -40.44K -290.00K -40.00K
Capital Expenditures -254.00K -496.00K -375.00K -82.00K -15.00K -5.00K -7.00K -9.00K -1K -14.00K -6.38K -2.13K -2.18K -7.55K -7.55K -112.01K -2.00K n/a n/a n/a n/a
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a -42.62M n/a n/a 1.03M 1.01M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -190.92M -154.41M -53.82M -39.38M -30.58M -26.57M -24.66M -31.06M -23.01M -55.75M -5.85M -475.35K -1.70M -1.00M -1.00M -2.73M n/a n/a n/a n/a n/a
Sales Maturities Of Investments 118.14M 185.09M 30.43M 44.09M 41.86M 19.57M 28.97M 15.06M 19.70M 42.68M 1.28M 2.25M -1.03M 900.00K 2.73M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a 26.00K -1K -1K -3.00K -2.00K -3.00K -2.00K -2.00K 42.62M 2.80K -3.62K -11.89K 1.24K -1.98K -3.74K n/a n/a n/a n/a n/a
Investing Cash Flow -73.04M 30.21M -23.76M 4.63M 11.26M -7.00M 4.30M -16.01M -3.31M -13.09M -4.57M 1.77M -1.71M 901.24K 1.72M -2.84M -2.00K n/a n/a n/a n/a
Debt Repayment 49.55M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 280.00K n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a -721.00K 22.91M 13.00K n/a 997.00K 1.56M 1.45M 8.00K 1.75M 109.58K n/a n/a -152.93K n/a n/a 529.00K 6.82K 40.44K 10.00K n/a
Financial Cash Flow 51.98M 10.78M 102.89M 23.79M n/a 22.65M 1.59M 12.04M 9.72M 16.64M 5.82M 3.49M 3.69M 152.93K n/a 5.03M 2.35M 537.80K 40.44K 290.00K n/a
Net Cash Flow -31.41M 13.01M 57.95M 15.97M -1.67M 1.03M 62.00K 694.00K 1.45M -510.00K -2.16M 2.92M 313.73K -517.23K -550.45K 349.09K 1.74M 176.19K n/a n/a -40.00K
Free Cash Flow -10.55M -28.41M -21.56M -12.52M -12.96M -14.66M -5.84M 4.65M -4.95M -4.08M -3.40M -2.30M -1.67M -1.43M -2.28M -1.95M -613.00K -361.61K -40.44K -290.00K -40.00K

Create Price Alert on ORMP

Your price alert will notify you when the stock price is above 2.35.

Add to Watchlist